Dr. Durack is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1700 Woodstock Rd
Durham, NC 27705Phone+1 919-257-1943- Is this information wrong?
Education & Training
- Oxford University1973 Doctor, Philosophy, 1973
- U Washington Affil Hosps1977
- University of WashingtonChief Residency, Internal Medicine, 1974 - 1975
- University of WashingtonResidency, Internal Medicine, 1975
- Oxford UniversityPhD, Experimental Medicine, 1970 - 1973
- Oxford UniversityPh.D., 1969 - 1973
- University of Western Australia Faculty of MedicineClass of 1969
- University of Western AustraliaMB, BS, Medicine, 1963 - 1968
- University of Western AustraliaB.S., With Honors
Certifications & Licensure
- NC State Medical License 1978 - 2024
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Honorary Life Member, Australasian Society of Infectious Diseases 2001
- Listed The International Who’s Who, 1997
- Listed The Best Doctors in America, 1992, 1995
- Join now to see all
Publications & Presentations
PubMed
- 118 citationsThe 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke Criteria.Vance G Fowler, David T Durack, Christine Selton-Suty, Eugene Athan, Arnold S Bayer
Clinical Infectious Diseases. 2023-08-22 - 73 citationsEffects of Antifungal Agents and γ Interferon on Macrophage Cytotoxicity for Fungi and Tumor CellsJohn R. Perfect, Donald L. Granger, David T. Durack
The Journal of Infectious Diseases. 1987-08-01 - 1718 citationsNew criteria for diagnosis of infective endocarditis : Utilization of specific echocardiographic findings. Duke Endocarditis ServiceDavid T. Durack, Andrea S. Lukes, David K. Bright
The American Journal of Medicine. 1994-03-01
Journal Articles
- Fostering partnerships between Industry and the Clinical Microbiology laboratoryDurack DT, Dunn JJ, J Clin Micro, 1/1/2011
- The cost-effectiveness of antiretroviral treatment strategies in resource-limited settingsBishai D, Colchero A, Durack DT, AIDS, 1/1/2007
- Prevention of Infective Endocarditis: Guidelines from the American Heart AssociationWilson W, Taubert KA, Gewitz, M, et al., Durack DT, Circulation, 1/1/2007
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Cost effectiveness of CD4 laboratory monitoring in HAARTBishai D, Colchero MA, Durack DT, 3rd International AIDS Society, Rio de Janiero, 1/1/2005
- Detection of Chlamydia pneumoniae by real-time strand displacementKacena, KA, Moore R, O’Keefe C, Quinn TC, Apfalter P, Durack DT, Gaydos CA, 4th European Chlamydia Congress, Helsinki, 1/1/2000
- Intestinal parasites associated with HIV infection n children with chronic diarrhea in Dar es Salaam, TanzaniaCegielski JP, Dukes CS, Durack DT, Mbise R, Minjas JN, Msengi AE, Redding-Lallinger R, Shao J, Vth International Conference on AIDS in Africa, Kinshasa, Zaire, 1/1/1990
- Join now to see all
Other
- 18 Infective Endocarditis. 7 Infectious DiseasesDurack DT, Karchmer AW, WebMD Inc
http://acpmedicine.com
New York - 1/1/2004 - Prevention of endocarditis: Dogma and debateDurack DT, Cardiology Today
1/1/1977 - Changes in the epidemiology of endocarditisDurack DT, Petersdorf RG, American Heart Association Monograph No. 52
1/1/1977 - Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: